Optimal colorectal cancer screening in states' low-income, uninsured populations - The case of South Carolina
© Health Research and Educational Trust.Objective To determine whether, given a limited budget, a state's low-income uninsured population would have greater benefit from a colorectal cancer (CRC) screening program using colonoscopy or fecal immunochemical testing (FIT). Data Sources/Study Setti...
| Main Authors: | Van Der Steen, A., Knudsen, A., Van Hees, F., Walter, G., Berger, F., Daguise, V., Kuntz, K., Zauber, A., Van Ballegooijen, M., Lansdorp_Vogelaar, Iris |
|---|---|
| Format: | Journal Article |
| Published: |
Blackwell Publishing Inc.
2015
|
| Online Access: | http://hdl.handle.net/20.500.11937/49791 |
Similar Items
Contribution of screening and survival differences to racial disparities in colorectal cancer rates
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)
Should colorectal cancer screening be considered in elderly persons without previous screening?: A cost-effectiveness analysis
by: Van Hees, F., et al.
Published: (2014)
by: Van Hees, F., et al.
Published: (2014)
A systematic comparison of microsimulation models of colorectal cancer: The role of assumptions about adenoma progression
by: Kuntz, K., et al.
Published: (2011)
by: Kuntz, K., et al.
Published: (2011)
Cost-savings to medicare from pre-medicare colorectal cancer screening
by: Goede, S., et al.
Published: (2015)
by: Goede, S., et al.
Published: (2015)
The value of models in informing resource allocation in colorectal cancer screening: The case of the Netherlands
by: Van Hees, F., et al.
Published: (2015)
by: Van Hees, F., et al.
Published: (2015)
The appropriateness of more intensive colonoscopy screening than recommended in medicare beneficiaries: A modeling study
by: Van Hees, F., et al.
Published: (2014)
by: Van Hees, F., et al.
Published: (2014)
Development of new non-invasive tests for colorectal cancer screening: The relevance of information on adenoma detection
by: Haug, U., et al.
Published: (2015)
by: Haug, U., et al.
Published: (2015)
Validation of Models Used to Inform Colorectal Cancer Screening Guidelines
by: Rutter, C., et al.
Published: (2015)
by: Rutter, C., et al.
Published: (2015)
Cost-effectiveness of colorectal cancer screening
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2011)
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2011)
Clarifying differences in natural history between models of screening: The case of colorectal cancer
by: Van Ballegooijen, M., et al.
Published: (2011)
by: Van Ballegooijen, M., et al.
Published: (2011)
The Impact of Uncertainty in Barrett's Esophagus Progression Rates on Hypothetical Screening and Treatment Decisions
by: Kroep, S., et al.
Published: (2015)
by: Kroep, S., et al.
Published: (2015)
Developing a score chart to improve risk stratification of patients with colorectal adenoma
by: Van Heijningen, E., et al.
Published: (2016)
by: Van Heijningen, E., et al.
Published: (2016)
The impact of stratifying by family history in colorectal cancer screening programs
by: Goede, S., et al.
Published: (2015)
by: Goede, S., et al.
Published: (2015)
Calibrating Parameters for Microsimulation Disease Models
by: Van Der Steen, A., et al.
Published: (2015)
by: Van Der Steen, A., et al.
Published: (2015)
Personalizing Colonoscopy Screening for Elderly Individuals Based on Screening History, Cancer Risk, and Comorbidity Status Could Increase Cost Effectiveness
by: Van Hees, F., et al.
Published: (2015)
by: Van Hees, F., et al.
Published: (2015)
Colorectal cancer deaths attributable to nonuse of screening in the United States
by: Meester, R., et al.
Published: (2015)
by: Meester, R., et al.
Published: (2015)
How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?
by: Wilschut, J., et al.
Published: (2011)
by: Wilschut, J., et al.
Published: (2011)
Colorectal cancer mortality prevented by use and attributable to nonuse of colonoscopy
by: Stock, C., et al.
Published: (2011)
by: Stock, C., et al.
Published: (2011)
Estimation of benefits, burden, and harms of colorectal cancer screening strategies: Modeling study for the US preventive services Task Force
by: Knudsen, A., et al.
Published: (2016)
by: Knudsen, A., et al.
Published: (2016)
Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
by: Goede, S., et al.
Published: (2013)
by: Goede, S., et al.
Published: (2013)
European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition Introduction
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)
State disparities in colorectal cancer rates: Contributions of risk factors, screening, and survival differences
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2015)
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2015)
Gender Differences in Fecal Immunochemical Test Performance for Early Detection of Colorectal Neoplasia
by: Kapidzic, A., et al.
Published: (2015)
by: Kapidzic, A., et al.
Published: (2015)
Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening
by: Goede, S., et al.
Published: (2017)
by: Goede, S., et al.
Published: (2017)
Nonbleeding adenomas: Evidence of systematic false-negative fecal immunochemical test results and their implications for screening effectiveness - A modeling study
by: Van Der Meulen, M., et al.
Published: (2016)
by: Van Der Meulen, M., et al.
Published: (2016)
Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths
by: Zauber, A., et al.
Published: (2012)
by: Zauber, A., et al.
Published: (2012)
Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening
by: Wilschut, J., et al.
Published: (2011)
by: Wilschut, J., et al.
Published: (2011)
Variation in adenoma detection rate and the lifetime benefits and cost of colorectal cancer screening: A microsimulation model
by: Meester, R., et al.
Published: (2015)
by: Meester, R., et al.
Published: (2015)
Family history and the natural history of colorectal cancer: Systematic review
by: Henrikson, N., et al.
Published: (2015)
by: Henrikson, N., et al.
Published: (2015)
Comparative economic evaluation of data from the ACRIN national CT colonography trial with three cancer intervention and surveillance modeling network microsimulations
by: Vanness, D., et al.
Published: (2011)
by: Vanness, D., et al.
Published: (2011)
Colorectal cancer screening in Australia
by: Kuipers, E., et al.
Published: (2017)
by: Kuipers, E., et al.
Published: (2017)
Attendance and diagnostic yield of repeated two-sample faecal immunochemical test screening for colorectal cancer
by: Kapidzic, A., et al.
Published: (2015)
by: Kapidzic, A., et al.
Published: (2015)
Radiation-related cancer risks from CT colonography screening: A risk-benefit analysis
by: Berrington De González, A., et al.
Published: (2011)
by: Berrington De González, A., et al.
Published: (2011)
State disparities in colorectal cancer mortality patterns in the United States
by: Naishadham, D., et al.
Published: (2011)
by: Naishadham, D., et al.
Published: (2011)
Cost Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer
by: Gini, A., et al.
Published: (2018)
by: Gini, A., et al.
Published: (2018)
Sojourn time of preclinical colorectal cancer by sex and age: Estimates from the german national screening colonoscopy database
by: Brenner, H., et al.
Published: (2011)
by: Brenner, H., et al.
Published: (2011)
A randomised comparison of two faecal immunochemical tests in population-based colorectal cancer screening
by: Grobbee, E., et al.
Published: (2016)
by: Grobbee, E., et al.
Published: (2016)
Do men and women need to be screened differently with fecal immunochemical testing? A cost-effectiveness analysis
by: Van Der Meulen, M., et al.
Published: (2017)
by: Van Der Meulen, M., et al.
Published: (2017)
Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing
by: van der Vlugt, M., et al.
Published: (2017)
by: van der Vlugt, M., et al.
Published: (2017)
Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018
by: Meester, R., et al.
Published: (2015)
by: Meester, R., et al.
Published: (2015)
Similar Items
-
Contribution of screening and survival differences to racial disparities in colorectal cancer rates
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012) -
Should colorectal cancer screening be considered in elderly persons without previous screening?: A cost-effectiveness analysis
by: Van Hees, F., et al.
Published: (2014) -
A systematic comparison of microsimulation models of colorectal cancer: The role of assumptions about adenoma progression
by: Kuntz, K., et al.
Published: (2011) -
Cost-savings to medicare from pre-medicare colorectal cancer screening
by: Goede, S., et al.
Published: (2015) -
The value of models in informing resource allocation in colorectal cancer screening: The case of the Netherlands
by: Van Hees, F., et al.
Published: (2015)